<DOC>
	<DOCNO>NCT01516580</DOCNO>
	<brief_summary>The aim trial test whether add 6 injection rituximab standard `` Lymphome malin B '' LMB chemotherapy regimen improve Event Free Survival ( EFS ) compare LMB chemotherapy alone child / adolescent advanced stage B-cell Non-Hodgkin Lymphoma ( NHL ) / B-Acute Leukemia ( B-AL ) ( stage III LDH &gt; Nx2 , stage IV B-AL ) .</brief_summary>
	<brief_title>Intergroup Randomized Trial Children Adolescents With B-Cell Non Hodgkin Lymphoma B-Acute Leukemia : Rituximab Evaluation High Risk Patients</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Leukemia , B-Cell</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Histologically cytologically proven Bcell malignancy , either Burkitt lymphoma BAL ( =Burkitt leukaemia = L3AL ) diffuse large Bcell NHL aggressive mature Bcell NHL non specify specifiable . Stage III elevate LDH level ( `` Bhigh '' ) , [ LDH &gt; twice institutional upper limit adult normal value ( &gt; Nx2 ) ] stage IV BAL . 6 month le 18 year age time consent . Males female reproductive potential must agree use effective contraceptive method treatment , end treatment : twelve month woman , take account characteristic rituximab five month men , take account characteristic methotrexate . Complete initial workup within 8 day prior treatment allow definite staging . Able comply schedule followup management toxicity . Signed informed consent patient and/or parent legal guardian Follicular lymphoma , MALT nodular marginal zone include therapeutic study Patients congenital immunodeficiency , chromosomal breakage syndrome , prior organ transplantation , previous malignancy type , know positive HIV serology . Evidence pregnancy lactation period . There exclusion criterion base organ function . Past current anticancer treatment except corticosteroid le one week . Tumor cell negative CD20 Prior exposure rituximab . Severe active viral infection , especially hepatitis B . Hepatitis B carrier status history HBV positive serology . Participation another investigational drug clinical trial . Patients , reason , able comply national legislation .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>